Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06924853 · ClinicalTrials.gov registry record · NA
Platelet Lysate vs Saline for Lumbosacral Radiculopathy
A NA study, sponsored by Regenexx.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06924853 is a NA study that was terminated before completion, run by Regenexx. The registered enrollment target is 2 participants.
The verdict
NCT06924853, a NA study, was terminated before completion, sponsored by Regenexx.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a randomized trial to evaluate and compare platelet lysate epidural injection to saline epidural injection for the treatment of lumbar radiculopathy (sciatica).
Interventions
- OTHER Saline control
- OTHER Platelet lysate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2025-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06924853
The ClinicalTrials.gov registry entry for NCT06924853 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenexx, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline control is the first listed.
NCT06924853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06924853 about?
NCT06924853 is a clinical study titled "Platelet Lysate vs Saline for Lumbosacral Radiculopathy". This is a randomized trial to evaluate and compare platelet lysate epidural injection to saline epidural injection for the treatment of lumbar radiculopathy (sciatica).
What is the current status of trial NCT06924853?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2025-07-01. Estimated completion is 2025-11-05.
What interventions are being tested in trial NCT06924853?
The interventions under investigation include: Saline control (OTHER), Platelet lysate (OTHER).
Who is sponsoring clinical trial NCT06924853?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.